EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
EVFM
Delisted
EVFM was delisted on the 10th of August, 2022.
99 hedge funds and large institutions have $86.3M invested in Evofem Biosciences, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 37 increasing their positions, 25 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
58% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 36
Holders
99
Holding in Top 10
–
Calls
$1.1M
Puts
$1.24M
Top Buyers
| 1 | +$5M | |
| 2 | +$2.19M | |
| 3 | +$1.93M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.24M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$831K |
Top Sellers
| 1 | -$6.67M | |
| 2 | -$5.38M | |
| 3 | -$3.97M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$2.34M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.7M |